DANAHER CORP
DHRNYSETrading Snapshot
- Day Range
- $223.08 β $226.46
- 52-Week Range
- $160.93 β $242.80
- Volume
- $2.33B
- Avg Volume
- $1.64B
- Shares Outstanding
- 703.0M
- Next Earnings
- Oct 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $24.57B
- Last Q Revenue
- $6.26B
- P/E Ratio
- 39.7
- P/S Ratio
- 6.3x
- EPS (TTM)
- $5.68
- Dividend Yield
- 0.64%
- Dilution (1yr)
- β3.6%
Why Investors Own DHR
- βHigh-growth profile β revenue up +5.7% YoY with expanding US Equity exposure.
- βHealthy economics β 68% gross margin and 20% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
DANAHER CORP
DHRAbout DANAHER CORP
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water typesβincluding ultra-pure, potable, industrial, waste, ground, source, and ocean waterβacross residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Danaher (NYSE:DHR) Stock Unloaded by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Danaher Corporation (NYSE: DHR). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,00

Danaher Schedules Third Quarter 2026 Earnings Conference Call
WASHINGTON, Sept. 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2026 on Wednesday, October 21, 2026 beginning at 8:00

Nykredit A S Takes Position in Danaher Corporation $DHR
Nykredit A S acquired a new position in shares of Danaher Corporation (NYSE: DHR) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 159,476

Danaher Announces Quarterly Dividend
WASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on Oct

ELV or DHR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?

Bank of America Corp DE Makes New Investment in Danaher Corporation $DHR
Bank of America Corp DE acquired a new stake in Danaher Corporation (NYSE: DHR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 5,217,586 shar